+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Personalized Medicine"

From
Peptide Microarray - Global Strategic Business Report - Product Thumbnail Image

Peptide Microarray - Global Strategic Business Report

  • Report
  • July 2025
  • 168 Pages
  • Global
From
From
Bioprocess Monitoring - Global Strategic Business Report - Product Thumbnail Image

Bioprocess Monitoring - Global Strategic Business Report

  • Report
  • July 2025
  • 170 Pages
  • Global
From
From
Cell Culture Vessels - Global Strategic Business Report - Product Thumbnail Image

Cell Culture Vessels - Global Strategic Business Report

  • Report
  • July 2025
  • 387 Pages
  • Global
From
Cell Culture Media - Global Strategic Business Report - Product Thumbnail Image

Cell Culture Media - Global Strategic Business Report

  • Report
  • July 2025
  • 673 Pages
  • Global
From
CRISPR-based Gene Editing - Global Strategic Business Report - Product Thumbnail Image

CRISPR-based Gene Editing - Global Strategic Business Report

  • Report
  • July 2025
  • 172 Pages
  • Global
From
From
From
DNA Synthesizer - Global Strategic Business Report - Product Thumbnail Image

DNA Synthesizer - Global Strategic Business Report

  • Report
  • July 2025
  • 221 Pages
  • Global
From
CRISPR and Cas Genes - Global Strategic Business Report - Product Thumbnail Image

CRISPR and Cas Genes - Global Strategic Business Report

  • Report
  • July 2025
  • 174 Pages
  • Global
From
From
gRNA - Global Strategic Business Report - Product Thumbnail Image

gRNA - Global Strategic Business Report

  • Report
  • July 2025
  • 475 Pages
  • Global
From
Continuous Bioprocessing - Global Strategic Business Report - Product Thumbnail Image

Continuous Bioprocessing - Global Strategic Business Report

  • Report
  • July 2025
  • 553 Pages
  • Global
From
From
Metabolism Assays - Global Strategic Business Report - Product Thumbnail Image

Metabolism Assays - Global Strategic Business Report

  • Report
  • July 2025
  • 463 Pages
  • Global
From
Cloning and Mutagenesis - Global Strategic Business Report - Product Thumbnail Image

Cloning and Mutagenesis - Global Strategic Business Report

  • Report
  • July 2025
  • 178 Pages
  • Global
From
Multiomics - Global Strategic Business Report - Product Thumbnail Image

Multiomics - Global Strategic Business Report

  • Report
  • July 2025
  • 209 Pages
  • Global
From
From
Loading Indicator

Personalized Medicine is a form of biotechnology that focuses on tailoring medical treatments to the individual needs of a patient. It is based on the idea that each person's genetic makeup, lifestyle, and environment can affect their response to a particular treatment. This approach to medicine has the potential to improve patient outcomes and reduce healthcare costs. Personalized Medicine utilizes a variety of technologies, such as genomics, proteomics, and metabolomics, to identify and analyze a patient's unique characteristics. This information is then used to develop treatments that are tailored to the individual's needs. Additionally, personalized medicine can be used to identify and monitor diseases, predict drug responses, and develop new treatments. Some companies in the Personalized Medicine market include 23andMe, Illumina, and Thermo Fisher Scientific. Show Less Read more